Background: Osteomyelitis is a well-recognized manifestation of melioi
dosis, a significant disease that is endemic in South-East Asia and no
rthern Australia. Diagnosis requires a high degree of clinical suspici
on and is dependent on microbiological confirmation; important clues a
re travel to or residence in an endemic area. Infection often but not
always occurs in well-recognized risk groups, especially diabetics and
alcoholics. Subacute presentations often mimic other disease processe
s and patients may not always be clinically septic. Treatment requires
surgical drainage in combination with multiple antibiotic therapy, in
cluding at least 2 weeks of intravenous ceftazidime and oral therapy c
ontinuing for 3-6 months. Non-compliance usually results in relapse, D
ue to the potential long latency of the disease and the possibility of
reactivation, follow-up should probably be life-long. Methods: A pros
pective study of 115 patients presenting with melioidosis between 1989
and 1995 was undertaken. Results: Four patients were found to have os
teomyelitis. Conclusion: it is Important to be aware of this condition
so that early treatment can be initiated.